Trial · NCT00734617
Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II
NCT00734617, Phase 3, Completed, Duke University; results first posted 2011-03-01
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II. Trials, record NCT00734617. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00734617
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II
- NCT number
- NCT00734617
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 479 participants, actual
- Lead sponsor
- Duke University
- Conditions
- Cigarette Smoking
- Interventions
- Nicotine Patch
- First posted
- 2008-08-14
- Last updated
- 2014-07-15
- Results first posted
- 2011-03-01
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Continuous Abstinence From Smoking at Ten Weeks Post-quit | May 2009 | Continuous abstinence from the target quit date through the end of treatment (10 weeks) was assessed based on self reports of continuous abstinence (i.e., no lapses) that were confirmed by end-expired CO levels ≤ 10 ppm. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Continuous Abstinence From Smoking at Ten Weeks Post-quit | May 2009 | participants | NUMBER |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Continuous Abstinence From Smoking at Ten Weeks Post-quit | Less Dependent | 21mg Nicotine Patch | 31 | participants | |
| Continuous Abstinence From Smoking at Ten Weeks Post-quit | More Dependent | 21mg Nicotine Patch | 21 | participants | |
| Continuous Abstinence From Smoking at Ten Weeks Post-quit | Less Dependent | 42mg Nicotine Patch | 17 | participants | |
| Continuous Abstinence From Smoking at Ten Weeks Post-quit | More Dependent | 42mg Nicotine Patch | 26 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Less Dependent | 249 | |
| Overall Study | STARTED | More Dependent | 230 | |
| Overall Study | COMPLETED | Less Dependent | 142 | |
| Overall Study | COMPLETED | More Dependent | 128 | |
| Overall Study | NOT COMPLETED | Less Dependent | 107 | |
| Overall Study | NOT COMPLETED | More Dependent | 102 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Less Dependent | ||
| Total, all-cause mortality | More Dependent | ||
| Total, other adverse events | Less Dependent | 0 | 249 |
| Total, other adverse events | More Dependent | 0 | 230 |
| Total, serious adverse events | Less Dependent | 0 | 249 |
| Total, serious adverse events | More Dependent | 0 | 230 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Less Dependent vs More Dependent: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00734617
GET https://conductscience.org/api/trials/v1/NCT00734617/registered